| PathID |
Pathway |
99P2 |
95P2 |
99P1 |
95P1 |
Enzyme |
KO |
| path:hsa04080 |
Neuroactive ligand-receptor interaction |
--- |
--- |
--- |
--- |
--- |
--- |
| path:hsa04080 |
Neuroactive ligand-receptor interaction |
--- |
--- |
--- |
IPI00440016; IPI00395827; |
--- |
K05221 |
| path:hsa04080 |
Neuroactive ligand-receptor interaction |
--- |
--- |
--- |
--- |
--- |
K04291 |
| path:hsa04080 |
Neuroactive ligand-receptor interaction |
--- |
--- |
--- |
--- |
--- |
K04287 |
| path:hsa04080 |
Neuroactive ligand-receptor interaction |
--- |
--- |
--- |
--- |
--- |
--- |
| path:hsa04080 |
Neuroactive ligand-receptor interaction |
--- |
--- |
--- |
--- |
--- |
K04292 |
| path:hsa04080 |
Neuroactive ligand-receptor interaction |
--- |
--- |
--- |
--- |
--- |
K04616 |
| path:hsa04080 |
Neuroactive ligand-receptor interaction |
--- |
--- |
--- |
--- |
--- |
K04299 |
| path:hsa01510 |
Neurodegenerative Disorders |
IPI00298547; |
IPI00298547; |
IPI00298547; |
IPI00298547; |
--- |
K05687 |
| path:hsa01510 |
Neurodegenerative Disorders |
--- |
IPI00023339; |
IPI00023339; |
IPI00023339; |
2.3.1.48 |
K04498 |
| path:hsa01510 |
Neurodegenerative Disorders |
--- |
--- |
--- |
--- |
--- |
K05626 |
| path:hsa01510 |
Neurodegenerative Disorders |
--- |
IPI00478752; IPI00020985; |
IPI00478752; IPI00020985; |
IPI00478752; IPI00020985; |
2.3.1.48 |
K04498 |
| path:hsa01510 |
Neurodegenerative Disorders |
IPI00219018; |
IPI00383758; IPI00219018; |
IPI00219018; |
IPI00383758; IPI00219018; |
1.2.1.12 |
K00134 |
| path:hsa01510 |
Neurodegenerative Disorders |
IPI00025363; |
IPI00025363; |
IPI00025363; |
IPI00025363; |
--- |
K05640 |
| path:hsa01510 |
Neurodegenerative Disorders |
IPI00021327; IPI00218070; |
IPI00021327; IPI00218070; |
IPI00021327; IPI00218070; |
IPI00021327; IPI00218070; |
--- |
K04364 |
| path:hsa01510 |
Neurodegenerative Disorders |
IPI00002335; |
IPI00002335; |
IPI00002335; |
IPI00002335; |
--- |
K04533 |
| path:hsa01510 |
Neurodegenerative Disorders |
--- |
IPI00294556; IPI00556131; |
--- |
IPI00294556; IPI00556131; |
--- |
K04531 |
| path:hsa01510 |
Neurodegenerative Disorders |
IPI00003362; |
IPI00003362; |
IPI00003362; |
IPI00003362; |
--- |
K03283 |
| path:hsa01510 |
Neurodegenerative Disorders |
--- |
IPI00020012; |
IPI00020012; |
IPI00020012; |
--- |
K05639 |
| path:hsa01510 |
Neurodegenerative Disorders |
IPI00021842; |
IPI00021842; |
IPI00021842; |
IPI00021842; |
--- |
K04524 |
| path:hsa01510 |
Neurodegenerative Disorders |
--- |
--- |
IPI00412568; IPI00219186; IPI00412681; IPI00412924; IPI00219187; IPI00219185; IPI00394658; IPI00219183; IPI00006608; |
IPI00412568; IPI00219186; IPI00412681; IPI00412924; IPI00219187; IPI00219185; IPI00394658; IPI00219183; IPI00006608; |
--- |
K04520 |
| path:hsa01510 |
Neurodegenerative Disorders |
--- |
IPI00217976; |
IPI00217976; IPI00025499; IPI00026836; IPI00220175; |
IPI00217976; |
--- |
K04380 |
| path:hsa01510 |
Neurodegenerative Disorders |
--- |
--- |
IPI00021751; |
IPI00021751; |
--- |
K04574 |
| path:hsa01510 |
Neurodegenerative Disorders |
--- |
--- |
--- |
--- |
--- |
K02583 |
| path:hsa01510 |
Neurodegenerative Disorders |
--- |
IPI00332282; IPI00470427; |
--- |
IPI00332282; IPI00470427; |
--- |
K04556 |
| path:hsa01510 |
Neurodegenerative Disorders |
--- |
IPI00056349; IPI00059165; IPI00075075; IPI00402151; |
--- |
IPI00056349; IPI00059165; IPI00075075; IPI00402151; |
--- |
K03361 |
| path:hsa01510 |
Neurodegenerative Disorders |
--- |
--- |
--- |
--- |
--- |
K05634 |
| path:hsa01510 |
Neurodegenerative Disorders |
--- |
--- |
--- |
IPI00219934; IPI00337671; IPI00377234; IPI00028077; IPI00514137; IPI00289615; |
--- |
K04505 |
| path:hsa01510 |
Neurodegenerative Disorders |
--- |
--- |
IPI00377103; IPI00218471; IPI00184584; |
IPI00377103; IPI00218471; IPI00184584; |
--- |
K04522 |
| path:hsa01510 |
Neurodegenerative Disorders |
--- |
--- |
--- |
IPI00024291; |
--- |
K02158 |
LiverbasePROTEOMESKY-LIVERHu1.0